Imigran (Sumatriptan)

Sumatriptan works by selectively stimulating serotonin 5‑HT1B and 5‑HT1D receptors on cranial blood vessels and trigeminal nerve endings. This action causes constriction of dilated intracranial vessels and blocks the release of inflammatory neuropeptides, interrupting the migraine cascade and reducing pain.

The dose of Imigran is determined by the prescribing healthcare professional based on individual patient needs and response. The prescriber will select the appropriate tablet strength and timing, typically advising the patient to take the medication at the first sign of a migraine.

Safety data for sumatriptan in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss treatment options with their healthcare provider.

To order Imigran, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details and any required import documentation.

Imigran (sumatriptan) belongs to the triptan class, which is generally more specific for migraine than non‑specific analgesics. Compared with other triptans such as rizatriptan, sumatriptan has a well‑established efficacy profile and is available in multiple formulations, but individual response and side‑effect tolerance may vary, so clinicians choose based on patient history.

Imigran tablets should be stored at below 25 °C in their original packaging, protected from moisture and direct sunlight. Keep the product out of reach of children and do not use after the expiry date printed on the label.

Imigran is taken orally as a tablet. The patient should swallow the tablet whole with a glass of water, preferably at the first sign of a migraine. It should not be crushed, chewed, or dissolved unless otherwise directed by a healthcare professional.

Serious risks include coronary artery spasm or myocardial infarction, especially in patients with underlying cardiovascular disease, and serotonin syndrome when combined with other serotonergic drugs. Severe allergic reactions such as anaphylaxis can also occur. Patients should seek immediate medical attention if they experience chest pain, severe hypertension, or signs of an allergic reaction.

Imigran is contraindicated in patients with known hypersensitivity to sumatriptan or other triptans, uncontrolled hypertension, recent myocardial infarction or stroke, and in those who have used ergot alkaloids within the past 24 hours. It should also be avoided in patients with certain cardiovascular conditions unless specifically approved by a physician.